[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Active Pharmaceutical Ingredient Market Research by Company, Type & Application 2013-2025

April 2018 | 154 pages | ID: GA2F76CF93EEN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

Market Segment as follows:

By Type
  • Synthetic API
  • Biotech API
  • Others
By Application
  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Oncology Drugs
  • Anti-diabetic Drugs
  • Cardiovascular Drugs
  • Central Nervous System Drugs (CNS Drugs)
  • Musculoskeletal Drugs
  • Other Drugs
By Company
  • Teva
  • Novartis
  • Pfizer
  • Johnson & Johnson
  • Mylan
  • North United States Pharmaceutical Group
  • Dr. Reddy’s Laboratories
  • Roche
  • Aurobindo pharma
  • Sun Pharmaceutical Industries
  • Boehringer Ingelheim GmbH
  • Bayer
  • BASF
  • DSM
  • Zhejiang Medicine
  • Biocon
  • Johnson Matthey
  • Hisun Pharmacy
  • Cambrex
  • Shandong Xinhua Pharmaceutical
  • Lonza group
  • Huahai Pharmaceutical
  • Haerbin Pharmaceutical Group
  • Cipla
  • Tian Yao
  • Lupin
  • North East Pharmaceutical
  • Albemarle
  • Shandong Lukang Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Bachem
The main contents of the report including:

Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Synthetic API
    1.1.2.2 Biotech API
    1.1.2.3 Others
  1.1.3 Market by Application
    1.1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    1.1.3.2 Oncology Drugs
    1.1.3.3 Anti-diabetic Drugs
    1.1.3.4 Cardiovascular Drugs
    1.1.3.5 Central Nervous System Drugs (CNS Drugs)
    1.1.3.6 Musculoskeletal Drugs
    1.1.3.7 Other Drugs
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 United States Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 United States
  2.2.1 United States Sales by Company
  2.2.2 United States Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 United States
  3.2.1 United States Sales by Type
  3.2.2 United States Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 United States
  4.2.1 United States Sales by Application
  4.2.2 United States Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Teva
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Novartis
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Pfizer
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Johnson & Johnson
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Mylan
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 North United States Pharmaceutical Group
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Dr. Reddy’s Laboratories
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Roche
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Aurobindo pharma
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Sun Pharmaceutical Industries
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Boehringer Ingelheim GmbH
6.12 Bayer
6.13 BASF
6.14 DSM
6.15 Zhejiang Medicine
6.16 Biocon
6.17 Johnson Matthey
6.18 Hisun Pharmacy
6.19 Cambrex
6.20 Shandong Xinhua Pharmaceutical
6.21 Lonza group
6.22 Huahai Pharmaceutical
6.23 Haerbin Pharmaceutical Group
6.24 Cipla
6.25 Tian Yao
6.26 Lupin
6.27 North East Pharmaceutical
6.28 Albemarle
6.29 Shandong Lukang Pharmaceutical
6.30 Jiangsu Hengrui Medicine
6.31 Bachem

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Mylan
Table Sales Revenue, Volume, Price, Cost and Margin of North United States Pharmaceutical Group
Table Sales Revenue, Volume, Price, Cost and Margin of Dr. Reddy’s Laboratories
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
Table Sales Revenue, Volume, Price, Cost and Margin of Aurobindo pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Sun Pharmaceutical Industries
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer
Table Sales Revenue, Volume, Price, Cost and Margin of BASF
Table Sales Revenue, Volume, Price, Cost and Margin of DSM
Table Sales Revenue, Volume, Price, Cost and Margin of Zhejiang Medicine
Table Sales Revenue, Volume, Price, Cost and Margin of Biocon
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson Matthey
Table Sales Revenue, Volume, Price, Cost and Margin of Hisun Pharmacy
Table Sales Revenue, Volume, Price, Cost and Margin of Cambrex
Table Sales Revenue, Volume, Price, Cost and Margin of Shandong Xinhua Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Lonza group
Table Sales Revenue, Volume, Price, Cost and Margin of Huahai Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Haerbin Pharmaceutical Group
Table Sales Revenue, Volume, Price, Cost and Margin of Cipla
Table Sales Revenue, Volume, Price, Cost and Margin of Tian Yao
Table Sales Revenue, Volume, Price, Cost and Margin of Lupin
Table Sales Revenue, Volume, Price, Cost and Margin of North East Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Albemarle
Table Sales Revenue, Volume, Price, Cost and Margin of Shandong Lukang Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Jiangsu Hengrui Medicine
Table Sales Revenue, Volume, Price, Cost and Margin of Bachem


LIST OF FIGURES

Figure Synthetic API Market Size and CAGR 2013-2017 (Million USD)
Figure Synthetic API Market Size and CAGR 2013-2017 (Volume)
Figure Synthetic API Market Forecast and CAGR 2018-2025 (Million USD)
Figure Synthetic API Market Forecast and CAGR 2018-2025 (Volume)
Figure Biotech API Market Size and CAGR 2013-2017 (Million USD)
Figure Biotech API Market Size and CAGR 2013-2017 (Volume)
Figure Biotech API Market Forecast and CAGR 2018-2025 (Million USD)
Figure Biotech API Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size and CAGR 2013-2017 (Million USD)
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size and CAGR 2013-2017 (Volume)
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Forecast and CAGR 2018-2025 (Volume)
Figure Oncology Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Oncology Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Oncology Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Oncology Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Anti-diabetic Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Anti-diabetic Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Anti-diabetic Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Anti-diabetic Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Cardiovascular Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Cardiovascular Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Cardiovascular Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cardiovascular Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Central Nervous System Drugs (CNS Drugs) Market Size and CAGR 2013-2017 (Million USD)
Figure Central Nervous System Drugs (CNS Drugs) Market Size and CAGR 2013-2017 (Volume)
Figure Central Nervous System Drugs (CNS Drugs) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Central Nervous System Drugs (CNS Drugs) Market Forecast and CAGR 2018-2025 (Volume)
Figure Musculoskeletal Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Musculoskeletal Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Musculoskeletal Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Musculoskeletal Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Other Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Other Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Other Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Other Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Size and CAGR 2013-2017 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Size and CAGR 2013-2017 (Volume)
Figure Global Active Pharmaceutical Ingredient Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Active Pharmaceutical Ingredient Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Active Pharmaceutical Ingredient Market Size and CAGR 2013-2017 (Million USD)
Figure United States Active Pharmaceutical Ingredient Market Size and CAGR 2013-2017 (Volume)
Figure United States Active Pharmaceutical Ingredient Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Active Pharmaceutical Ingredient Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Active Pharmaceutical Ingredient SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications